Expression, Purification, and Characterization of C-Terminal Amidated Glucagon in Streptomyces lividans |
Qi, Xiaoqiang
(Ministry of Health Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College)
Jiang, Rong (Ministry of Health Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College) Yao, Cheng (Ministry of Health Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College) Zhang, Ren (Ministry of Health Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College) Li, Yuan (Ministry of Health Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College) |
1 | Anne, J. and L. Van Mellaert. 1993. Streptomyces Iividans as host for heterologous protein production. FEMS Microbiol. Lett. 114: 121-128 DOI ScienceOn |
2 | Bender, E., K. P. Koller and J. W. Engels. 1990. Secretory synthesis of human interleukin-2 by Streptomyces lividans. Gene. 86: 227-232 DOI ScienceOn |
3 | Binnie, C., D. Jenish, D. Cossar, A. Szabo, D. Trudeau, P. Krygsman, L. T. Malek, and D. I. H. Stewart. 1997. Expression and characterization of soluble human erythropoietin receptor made in Streptomyces lividans 66. Protein Expr. Purif. 11: 271-278 DOI ScienceOn |
4 | Brawner, M., G. Poste, M. Rosenberg, and J. Westpheling. 1991. Streptomyces: A host for heterologous gene expression. Curr. Opin. Biotechnol. 2: 674-681 DOI ScienceOn |
5 | Chiasson, J. L. and A. D. Cherrington. 1983. In: Glucagon and Liver Glucose Output in Vivo (Glucagon I, Handbook of Experimental Pharmacology), pp. 361-382. Springer-Verlag, Berlin, Germany |
6 | Choi, N. S., K. H. Yoo, K. S. Yoon, K. T. Chang, P. J. Maeng, and S. H. Kim. 2005. Identification of recombinant subtilisins. J. Microbiol. Biotechnol. 15: 35-39 과학기술학회마을 |
7 | Stewart, J. M., E. J. York, R. L. Baldwin, and K. R. Shoemaker. 1985. Nature of the charged-group effect on the stability of the C-peptide helix. Proc. Natl. Acad. Sci. USA 82: 2349-2353 |
8 | Lichenstein, H., M. E. Brawner, L. M. Miles, C. A. Meyers, P. R. Young, P. L. Simon, and T. Eckhardt. 1988. Secretion of interleukin-1 beta and Escherichia coli galactokinase by Streptomyces lividans. J. Bacteriol. 170: 3924-3929 DOI |
9 | Moody, A. J., F. Norris, and K. Norris. 1987. The secretion of glucagon by transformed yeast strains. FEBS Lett. 212: 302- 306 DOI ScienceOn |
10 | Ray, M. V., P. Van Duyne, and A. H. Bertelsen. 1993. Production of recombinant salmon calcitonin by in vitro amidation of an Escherichia coli produced precursor peptide. Biotechnology (NY) 11: 64-70 DOI |
11 | White, J. W. and G. F. Saunders. 1986. Structure of the human glucagon gene. Nucleic Acids Res. 14: 4719-4730 DOI ScienceOn |
12 | Fornwald, J. A., M. J. Donovan, R. Gerber, J. Keller, D. P. Taylor, E. J. Arcuri, and M. E. Brawner. 1993. Soluble forms of the human T cell receptor CD4 are efficiently expressed by Streptomyces lividans. Biotechnology 11: 1031-1036 DOI ScienceOn |
13 | Brawner, M. E. 1994. Advances in heterologous gene expression by Streptomyces. Curr. Opin. Biotechnol. 5: 475-481 DOI ScienceOn |
14 | Roman Esipov, S., N. Vasily Stepanenko, and I. Alexandr Gurevich. 2006. Production and purification of recombinant human glucagon overexpressed as intein fusion protein in Escherichia coli. Protein Peptide Lett. 13: 343-347 DOI ScienceOn |
15 | Staub, A., L. Sinn, and O. K. Behrens. 1955. Purification and crystallization of glucagon. J. Biol. Chem. 214: 619-632 |
16 | Ausubel, F. M. 1995. Short Protocols in Molecular Biology, 3rd Ed. John Wiley & Sons, Inc |
17 | Wu, B.Y. and Y. Li. 2000. Studies of cloning and expression of rat -amidase gene in Streptomyces lividans. Chin. J. Biotechnol. 16: 574-577 |
18 | Unger, R. H. 1976. Diabetes and the alpha cell. Diabetes. 25: 136-151 DOI |
19 | Binnie, C., J. D. Cossar, and D. I. H. Stewart. 1997. Heterologous biopharmaceutical protein expression in Streptomyces. TIBTECH 15: 315-320 DOI ScienceOn |
20 | Na, K. H., S. C. Kim, K. S. Seo, S. H. Lee, W. B. Kim, and K. C. Lee. 2005. Purification and characterization of recombinant human follicle stimulating hormone produced by Chinese hamster ovary cells. J. Microbiol. Biotechnol. 15: 395-402 과학기술학회마을 |
21 | Van Mellaert, L., C. Dillen, P. Proost, E. Sablon, R. DeLeys, A. Van Broekhoven, H. Heremans, J. Van Damme, H. Eyssen, and J. Anne. 1994. Efficient secretion of biologically active mouse tumor necrosis factor by Streptomyces lividans. Gene 150: 153-158 DOI ScienceOn |
22 | Kimball, C. P. and J. R. Murlin. 1923. Aqueous extracts of pancreas III. Some precipitation reactions of insulin. J. Biochem. 58: 337-346 |
23 | Hong, B., B. Wu, and Y. Li. 2003. Production of C-terminal amidated recombinant salmon calcitonin in Streptomyces lividans. Appl. Biochem. Biotechnol. 110: 113-123 |
24 | Ishizaki, J., M. Tamaki, M. Shin, H. Tsuzuki, K. Yoshikawa, H. Teraoka, and N. Yoshida. 1992. Production of recombinant human glucagon in the form of a fusion protein in Escherichia coli recovery of glucagon by sequence-specific digestion. Appl. Microbiol. Biotechnol. 36: 483-486 |
25 | Kieser, T., M. J. Bibb, M. J. Buttner, K. F. Chater, and D. A. Hopwood. 2000. Practical Streptomyces Genetics. Crowes, Norwich, England |
26 | Krstenansky, J. L., D. Trivedi, D. Johnson, and V. J. Hruby. 1986. Conformational considerations in the design of a glucagon analogue with increased receptor binding and adenylate cyclase potencies. J. Am. Chem. Soc. 108: 1696-1698 DOI |
27 | Unson, C. G., D. Andreu, M. Ellen Gurzenda, and R. B. Merrifield. 1987. Synthetic peptide antagonists of glucagons. Proc. Natl. Acad. Sci. USA 84: 4083-4087 |